ID

42022

Descrizione

https://clinicaltrials.gov/show/NCT00989664 Patient Withdrawal from Study, Long Term Follow-Up for Survival & Disease Status and Notification of Patient Death Study ID: 104504 Clinical Study ID: BEX104504 Study Title: Multicenter, Pivotal Phase III Study of Iodine-131 Anti-B1 Antibody (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas that have Transformed to Higher Grade Histologies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00989664 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

collegamento

https://clinicaltrials.gov/show/NCT00989664

Keywords

versioni (2)
  1. 25/05/18 25/05/18 -
  2. 15/03/21 15/03/21 - Dr. rer. medic Philipp Neuhaus
Titolare del copyright

GlaxoSmithKline (GSK)

Caricato su

15 marzo 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Multicenter, Pivotal Phase III Study of Iodine-131 Anti-B1 Antibody (Murine) Radioimmunotherapy NCT00989664

Inglese

Patient Withdrawal from Study, Long Term Follow-Up for Survival & Disease Status and Notification of Patient Death

1 moduli  
Patient Withdrawal from Study
Descrizione

Patient Withdrawal from Study

Alias
UMLS CUI-1
C0422727
Date of wlthdrawal from study
Descrizione

Withdrawal date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0011008
Reason for withdrawal from study (check primary reason only)
Descrizione

Reason for withdrawal from study

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0008976
Date of last contact
Descrizione

Date of last contact

Tipo di dati

date

Alias
UMLS CUI [1]
C0805839
Explanation of withdrawal (when appropriate)
Descrizione

Explanation of withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0681841
Long Term Follow-Up for Survival & Disease Status
Descrizione

Long Term Follow-Up for Survival & Disease Status

Alias
UMLS CUI-1
C1517942
Date of status
Descrizione

Date of status

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0449437
Patient status:
Descrizione

Patient status

Tipo di dati

integer

Alias
UMLS CUI [1]
C0449437
How was contact made:
Descrizione

Way of contact

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C0337611
Other way of contact
Descrizione

Other way of contact

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C0337611
Does the patient have an ongoing response to lodine-131 Tositumomab?
Descrizione

(If yes, please complete Response Assessment Forms if applicable.)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C0521982
Has any additional therapy for NHL been administered?
Descrizione

Since the time the last LTFU was completed, has any of the following occured: (If yes, specify below and provide applicable data)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1706712
Has the patient had a documented diagnosis of myelodysplasia?
Descrizione

Myelodysplasia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0026985
If yes, date of diagnosis:
Descrizione

(complete both AE & SAE CRFs)

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C0026985
Has the patient had a documented diagnosis of AML?
Descrizione

AML

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023467
If yes, date of diagnosis:
Descrizione

(complete both AE & SAE CRFs)

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C0023467
Has the patient had a diagnosis of another malignancy?
Descrizione

Other malignancy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205394
If yes, date of diagnosis:
Descrizione

(complete both AE & SAE CRFs)

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C0006826
UMLS CUI [1,3]
C0205394
Type of malignancy:
Descrizione

Type of malignancy

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332307
Subsequent NHL Therapy since last LTFU
Descrizione

Subsequent NHL Therapy since last LTFU

Alias
UMLS CUI-1
C2734539
UMLS CUI-2
C0008972
Subsequent NHL Therapy since last LTFU
Descrizione

Subsequent NHL Therapy since last LTFU

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2734539
UMLS CUI [1,2]
C0008972
Therapy Start date
Descrizione

Therapy Start date

Tipo di dati

date

Alias
UMLS CUI [1]
C3173309
Therapy Stop Date
Descrizione

Therapy Stop Date

Tipo di dati

date

Alias
UMLS CUI [1]
C1531784
Total # of Cycles
Descrizione

Total # of Cycles

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C1302181
Laboratory tests
Descrizione

Laboratory tests

Alias
UMLS CUI-1
C0022885
TSH Date
Descrizione

TSH Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0040160
UMLS CUI [1,2]
C0011008
Result:
Descrizione

TSH Result

Tipo di dati

float

Unità di misura
  • 𝞵IU/mL
Alias
UMLS CUI [1,1]
C0202230
UMLS CUI [1,2]
C1274040
𝞵IU/mL
Has the patient begun thyroid replacement therapy since the last LTFU?
Descrizione

Thyroid replacement therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2242640
If yes, start date:
Descrizione

Therapy start date

Tipo di dati

date

Alias
UMLS CUI [1]
C3173309
Drug Name:
Descrizione

Drug Name

Tipo di dati

text

Alias
UMLS CUI [1]
C0013227
Was a HAMA obtained since the last LTFU?
Descrizione

HAMA

Tipo di dati

integer

Alias
UMLS CUI [1]
C1291910
If yes, enter accession #
Descrizione

Accession #

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C1510755
UMLS CUI [1,2]
C2826726
Administration
Descrizione

Administration

Alias
UMLS CUI-1
C1320722
Investigator Signature:
Descrizione

Investigator Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Date
Descrizione

Date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Notification of death
Descrizione

Notification of death

Alias
UMLS CUI-1
C0422202
UMLS CUI-2
C0007465
Cause of death (check one)
Descrizione

If cause of death was related to complications of treatment, please describe or reference forms on which Information is recorded.

Tipo di dati

integer

Alias
UMLS CUI [1]
C0007465
Other Cause of Death:
Descrizione

Other Cause of Death

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0007465
UMLS CUI [1,2]
C1521902
Relationship of study drug to patient's death (check one)
Descrizione

Relationship of study drug to patient's death

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0007465
UMLS CUI [1,2]
C0304229
Source of Information concerning death of patient
Descrizione

Source of Information concerning death of patient

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0011065
UMLS CUI [1,3]
C0449416
Other Source of Information concerning death of patient
Descrizione

Other Source

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0683836
UMLS CUI [1,2]
C0011065
UMLS CUI [1,3]
C0205394
Ritorna all'inizio della pagina

Similar models

Patient Withdrawal from Study, Long Term Follow-Up for Survival & Disease Status and Notification of Patient Death

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Patient Withdrawal from Study
C0422727 (UMLS CUI-1)
Withdrawal date
Item
Date of wlthdrawal from study
date
C2349954 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Reason for withdrawal from study (check primary reason only)
integer
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Reason for withdrawal from study
Code List
Reason for withdrawal from study (check primary reason only)
CL Item
Patient was lost to follow-up (explain below). (1)
CL Item
Patient wished to withdraw from study (explain below). (2)
CL Item
Patient received alternative therapy (explain below). (3)
CL Item
Patient had progressive disease. (4)
CL Item
Patient died (complete Form 39). (5)
CL Item
Other (specify) (6)
Date of last contact
Item
Date of last contact
date
C0805839 (UMLS CUI [1])
Explanation of withdrawal
Item
Explanation of withdrawal (when appropriate)
text
C2349954 (UMLS CUI [1,1])
C0681841 (UMLS CUI [1,2])
Item Group
Long Term Follow-Up for Survival & Disease Status
C1517942 (UMLS CUI-1)
Date of status
Item
Date of status
date
C0011008 (UMLS CUI [1,1])
C0449437 (UMLS CUI [1,2])
Item
Patient status:
integer
C0449437 (UMLS CUI [1])
Patient status
Code List
Patient status:
CL Item
Alive (1)
CL Item
Dead (complete "Notification of Patient Death" Form) (2)
CL Item
Lost to follow-up (3)
Item
How was contact made:
integer
C1705415 (UMLS CUI [1,1])
C0337611 (UMLS CUI [1,2])
Way of contact
Code List
How was contact made:
CL Item
Tumor registry (1)
CL Item
Contact with patient (2)
CL Item
Contact with MD (3)
CL Item
Contact with family (4)
CL Item
Other (5)
Other way of contact
Item
Other way of contact
text
C1705415 (UMLS CUI [1,1])
C0337611 (UMLS CUI [1,2])
Response to lodine-131 Tositumomab
Item
Does the patient have an ongoing response to lodine-131 Tositumomab?
boolean
C0768182 (UMLS CUI [1,1])
C0521982 (UMLS CUI [1,2])
Additional Therapy
Item
Has any additional therapy for NHL been administered?
boolean
C1706712 (UMLS CUI [1])
Myelodysplasia
Item
Has the patient had a documented diagnosis of myelodysplasia?
boolean
C0026985 (UMLS CUI [1])
Myelodysplasia diagnosis date
Item
If yes, date of diagnosis:
date
C2316983 (UMLS CUI [1,1])
C0026985 (UMLS CUI [1,2])
AML
Item
Has the patient had a documented diagnosis of AML?
boolean
C0023467 (UMLS CUI [1])
AML diagnosis date
Item
If yes, date of diagnosis:
date
C2316983 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])
Other malignancy
Item
Has the patient had a diagnosis of another malignancy?
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Other malignancy diagnosis date
Item
If yes, date of diagnosis:
date
C2316983 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Type of malignancy
Item
Type of malignancy:
text
C0006826 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Item Group
Subsequent NHL Therapy since last LTFU
C2734539 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Subsequent NHL Therapy since last LTFU
Item
Subsequent NHL Therapy since last LTFU
text
C2734539 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
Therapy Start date
Item
Therapy Start date
date
C3173309 (UMLS CUI [1])
Therapy Stop Date
Item
Therapy Stop Date
date
C1531784 (UMLS CUI [1])
Total # of Cycles
Item
Total # of Cycles
integer
C0449788 (UMLS CUI [1,1])
C1302181 (UMLS CUI [1,2])
Item Group
Laboratory tests
C0022885 (UMLS CUI-1)
TSH Date
Item
TSH Date
date
C0040160 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
TSH Result
Item
Result:
float
C0202230 (UMLS CUI [1,1])
C1274040 (UMLS CUI [1,2])
Thyroid replacement therapy
Item
Has the patient begun thyroid replacement therapy since the last LTFU?
boolean
C2242640 (UMLS CUI [1])
Therapy start date
Item
If yes, start date:
date
C3173309 (UMLS CUI [1])
Drug Name
Item
Drug Name:
text
C0013227 (UMLS CUI [1])
Item
Was a HAMA obtained since the last LTFU?
integer
C1291910 (UMLS CUI [1])
HAMA
Code List
Was a HAMA obtained since the last LTFU?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not applicable (3)
Accession #
Item
If yes, enter accession #
integer
C1510755 (UMLS CUI [1,1])
C2826726 (UMLS CUI [1,2])
Item Group
Administration
C1320722 (UMLS CUI-1)
Investigator Signature
Item
Investigator Signature:
text
C2346576 (UMLS CUI [1])
Date
Item
Date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Notification of death
C0422202 (UMLS CUI-1)
C0007465 (UMLS CUI-2)
Item
Cause of death (check one)
integer
C0007465 (UMLS CUI [1])
Cause of death
Code List
Cause of death (check one)
CL Item
Progression of lymphoma (1)
CL Item
Complications related to drug (complete Adverse Experiences form) (2)
CL Item
Other (specify) (3)
Other Cause of Death
Item
Other Cause of Death:
text
C0007465 (UMLS CUI [1,1])
C1521902 (UMLS CUI [1,2])
Item
Relationship of study drug to patient's death (check one)
integer
C0007465 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Relationship of study drug to patient's death
Code List
Relationship of study drug to patient's death (check one)
CL Item
None (1)
CL Item
Remote (2)
CL Item
Possible (3)
CL Item
Probable (4)
Item
Source of Information concerning death of patient
integer
C0030705 (UMLS CUI [1,1])
C0011065 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])
Source of Information concerning death of patient
Code List
Source of Information concerning death of patient
CL Item
Hospital physician (1)
CL Item
Patient's physician (2)
CL Item
Family (3)
CL Item
Newspaper (obituary) (4)
CL Item
Tumor registry (5)
CL Item
Other (specify) (6)
Other Source
Item
Other Source of Information concerning death of patient
text
C0683836 (UMLS CUI [1,1])
C0011065 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial